The hyper-inflammatory SARS-CoV-2-induced ARDS patient micro-environment licenses MSCs and enhances their therapeutic efficacy in a model of acute lung injury
Courteney Tunstead(National University of Ireland, Maynooth), Karen English(National University of Ireland, Maynooth), Ritu Negi(Ollscoil na Gaillimhe – University of Galway), Alison Bell(Ollscoil na Gaillimhe – University of Galway), Evelina Volkova(National University of Ireland, Maynooth), Claúdia C. dos Santos(St. Michael's Hospital), John G. Laffey(University Hospital Galway), Ian J. Hawthorne(National University of Ireland, Maynooth), Hazel Dunbar(National University of Ireland, Maynooth)
Cited by 1
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
The ICM research agenda on intensive care unit-acquired weakness
|Intensive Care Medicine|2017|255
The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
|Frontiers in Immunology|2019|100